The ability of MicroScan rapid panels (Baxter MicroScan, West Sacramento, Calif.) to detect oxacillin resistance in 92 clinical isolates of Staphylococcus aureus and 103 coagulase-negative staphylococci was evaluated by comparing results with those of MicroScan 24-h MIC panels and, to resolve discrepancies, oxacillin agar screening. Both panels were interpreted by the MicroScan WalkAway-96 system. Rapid panels detected 96.7% of resistant S. aureus isolates and 72% of resistant coagulase-negative staphylococci, 22 of which did not grow in the panels.
Strains of Staphylococcus aureus resistant to oxacillin (methicillin) were first recognized in the United States in the mid-1970s and are now a significant problem in several institutions (1, 2) . More recently, coagulase-negative staphylococci emerged as important nosocomial pathogens; consequently, detection of oxacillin resistance in these organisms also is a concern (8, 9) . Most oxacillin-resistant (OR) staphylococci are heterogeneous, recognized only after specific manipulations of susceptibility test systems (3) . One method is the oxacillin agar screen (Mueller-Hinton agar with 4% NaCl and 6 1xg of oxacillin per ml incubated for 24 h at 35°C) (7). For disk diffusion and broth dilution testing, the following guidelines published by the National Committee for Clinical Laboratory Standards should be followed: (i) test oxacillin, (ii) prepare the inoculum directly from overnight growth on an agar plate, (iii) incubate at 35°C for 24 h, and (iv) for broth dilution, supplement the medium with 2% NaCl (4, 5) .
Today, many clinical microbiology laboratories use automated systems rather than conventional methods for susceptibility testing. Moreover, in response to the current demand for rapid turnaround times, systems that require shorter incubation times have been developed. These automated systems designed for rapid testing must be able to reliably detect OR staphylococci.
MicroScan (Baxter MicroScan, West Sacramento, Calif.) 24-h MIC panels are reliable for the detection of OR S. aureus and coagulase-negative staphylococci (10) . Recently, Baxter developed rapid MicroScan panels, the wells of which contain antimicrobial agents diluted in water containing fluorogenic compounds. The panels are incubated in the WalkAway system, and after 3.5 to 15 h, the instrument interprets the MIC by measuring the increase in fluorescence in the dilutions of antimicrobial agents and comparing it with the increase in fluorescence in growth control wells. For staphylococci, two control wells, one with and one without NaCl, are evaluated. The purpose of the study described here was to determine whether these rapid panels can reliably detect OR staphylococci.
Organisms Statistics. A z score (6) was calculated to determine whether the reliability of the rapid panels for detection of OR was significantly different from that of the 24-h MIC panels plus agar screening (as described above).
The results of the study are summarized in Table 1 initially, 100 were OR by 24-h MIC panels, 1 was susceptible, and 2 did not grow; by testing with the rapid panels, 72 were resistant, 9 were susceptible, and 22 did not grow. After resolving discrepancies by retesting and oxacillin agar screening, 100 coagulase-negative staphylococci were resistant and 3 were susceptible. MIC 24-h panels detected 97% of resistant strains initially; 3 with a resistance result on both testing occasions were susceptible by oxacillin agar screening. Rapid panels detected only 72 of the 100 (72%) resistant isolates on initial testing (P < 0.001) (92.3% of the resistant strains that grew) and gave no false-resistant results. When rapid panels were repeat tested, nine additional coagulase-negative staphylococci were OR (five that first had a result of susceptible and four that had not grown).
In summary, MicroScan rapid panels can provide antimicrobial susceptibility results in 3.5 Current recommendations for the detection of OR staphylococci include incubation for at least 24 h. MicroScan rapid panels allow reliable detection of OR S. aureus in 3.5 to 15 h, and most within 4.5 to 7 h. Coagulase-negative staphylococci, however, often fail to grow in these panels or do not produce enzymes that hydrolyze the fluorogenic compounds. Therefore, until this problem is corrected, use of the rapid panels for susceptibility testing of coagulase-negative staphylococci is not recommended.
